Latest filing published 30 Apr 2015 for T2 Biosystems, Inc., €41k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -39.5%Entry US$1,539.00 · Close at T+365 US$931.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sarah O. Kalil: trading record in brief
Sarah O. Kalil is a declared insider of T2 Biosystems, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 12 August 2014 and the latest from 27 March 2015.
Purchases make up the whole of the open-market record (2 purchases, €165k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise. So far in 2015, the count stands at 1 purchase and no sales.
On 30 April 2015 came the latest disclosure, an open-market purchase for €41k in T2 Biosystems, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sarah O. Kalil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$11.00Common Stock, par value $0.001SEC:0001104659-15-032480:0Canonical exit: 10 Nov 2014 (T+90)
- 41,500 shares@ US$3.22Common Stock, par value $0.001SEC:0001104659-15-024666:0
2 of 2 declarations